-+ 0.00%
-+ 0.00%
-+ 0.00%

According to the Zhitong Finance App, Shiyao Group (01093.HK) issued an announcement. Nidanib ethanesulfonate inhalation powder developed by the Group has been approved by the China National Drug Administration and can conduct clinical trials in China.

Zhitongcaijing·01/02/2026 11:57:05
Listen to the news
According to the Zhitong Finance App, Shiyao Group (01093.HK) issued an announcement. Nidanib ethanesulfonate inhalation powder developed by the Group has been approved by the China National Drug Administration and can conduct clinical trials in China.